Benefits of Biotechnology --A United States Case Study

JIRCAS international symposium series
ISSN 13406108
書誌レコードID(総合目録DB) AA1100908X
本文フルテキスト
The commercialization of plant biotechnology products in the United States offers evidence that biotechnology will deliver solutions to our world's growing food needs. Global pressures are driving the need for genetically modified plants. The U.S. regulatory process is a model of coordination of the review of new plant biotechnology products within an existing regulatory framework. The concept of substantial equivalence -- judging plant biotechnology products to determine their nutritional, compositional and safety equivalence to foods developed through traditional plant breeding -- has been critical in the United States to the successful commercialization of products of biotechnology. This concept has been the key to the implementation of workable, effective guidelines for assessing food safety. Media and consumer acceptance have been gained through the cooperative efforts of business, government, and trade and health organizations. Similar cooperation on a global scale will help biotechnology fulfill its long-term promise of providing safe, abundant food and a healthy environment worldwide.
作成者 Edward E. Debus
公開者 Japan International Research Center for Agricultural Sciences
オンライン掲載日
5
開始ページ 191
終了ページ 198
言語 eng

関連する刊行物